Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical and biotechnology companies, announced today the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada. The project added three new sterile processing suites and an active pharmaceutical ingredient (API) manufacturing suite, and…